about
Identification and proportion of the enantiomers of the antihypertensive drug chlortalidone in its Form II by high quality single-crystal X-ray diffraction data.On-Line Restricted Access Molecularly Imprinted Solid-Phase Extraction of Selective Serotonin Reuptake Inhibitors Directly from Untreated Human Plasma Samples Followed by HPLC-UV Analysis.Enantioselective determination of metoprolol acidic metabolite in plasma and urine using liquid chromatography chiral columns: applications to pharmacokinetics.Influence of N-hexane inhalation on the enantioselective pharmacokinetics and metabolism of verapamil in rats.Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats.Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of beta blockers using a new mechanism-based PK-PD modelling approach.Stereoselective analysis of metoprolol and its metabolites in rat plasma with application to oxidative metabolism.Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.Simultaneous analysis of the enantiomers of verapamil and norverapamil in rat plasma by liquid chromatography-tandem mass spectrometry.In vivo schistosomicidal activity of 7-epiclusianone and its quantification in the plasma of healthy and Schistosoma mansoni infected mice using UPLC-MS/MS.Dialkyl phosphates determination by gas chromatography: Evaluation of a microwave-assisted derivatization†.On-line restricted access molecularly imprinted solid phase extraction of ivermectin in meat samples followed by HPLC-UV analysis.Direct doping analysis of beta-blocker drugs from urinary samples by on-line molecularly imprinted solid-phase extraction coupled to liquid chromatography/mass spectrometry
P50
Q31015686-44569118-6BCD-49AF-8911-1239D46A5559Q40407819-E2C2216A-1529-40B2-8228-B28085E0111DQ44249402-28F23178-961D-44F3-9A54-3F79721E04ECQ46116003-068EA9E5-0729-4314-BAEE-2230184A4519Q46152463-4B07074E-A143-42D8-A5E4-8710B7C67487Q46178849-57EA7AE3-B9A0-42F1-A455-9A4D01F87BC0Q46609045-7D8B04E9-79F3-4408-A6D0-391520E1BD7EQ46630335-8920B63A-82A5-4079-861A-BF65FC11D4F5Q46915565-2321755E-9FCE-42C2-B77D-694B11DC60AAQ50097334-FD68420F-B902-4685-975A-9CA2769D6EDCQ52803673-1563F2E4-B81D-43D1-98F2-8715E14AAF0AQ52839373-1F4314E5-9C2B-4F10-8B61-2C4816778D15Q86720886-D2421695-C068-4E88-927B-308EC627264E
P50
description
Forscher
@de
investigador
@es
onderzoeker
@nl
researcher
@en
ricercatore
@it
研究員
@ja
研究者
@zh
name
Vanessa Bergamin Boralli
@en
Vanessa Bergamin Boralli
@nl
type
label
Vanessa Bergamin Boralli
@en
Vanessa Bergamin Boralli
@nl
prefLabel
Vanessa Bergamin Boralli
@en
Vanessa Bergamin Boralli
@nl
P106
P31
P496
0000-0002-7033-0350